Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis

This study establishes a proof-of-concept that a tattoo device can target intra-dermal drug delivery against cutaneous leishmaniasis (CL). The selected drug is oleylphosphocholine (OlPC) formulated as liposomes, particles known to be prone to macrophage ingestion. We first show that treatment of cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Shio, Marina Temi, Paquet, Marilene, Martel, Caroline, Bosschaerts, Tom, Stienstra, Stef, Olivier, Martin, Fortin, Anny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932479/
https://www.ncbi.nlm.nih.gov/pubmed/24561704
http://dx.doi.org/10.1038/srep04156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932479/
https://www.ncbi.nlm.nih.gov/pubmed/24561704
http://dx.doi.org/10.1038/srep04156

Ejemplares similares